NIH-funded research NIH-funded research

How bacteria transport proteins across their membranes

Official title: Protein Transport Across Membrane by Bacterial Pathogens

Funded at University of Missouri-Columbia · NIH-11066531 · Data updated 2026-11-12

This study looks at how certain bacteria, like Legionella pneumophila, move important proteins into our cells, which helps them cause infections and resist antibiotics, and by understanding this process better, we hope to find new ways to fight these infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Missouri-Columbia
NIH-funded
Lab location1 site (Columbia, United States)
Project startJuly 7, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$388,579
NIH project number5R35GM150663-03
Project IDNIH-11066531 on NIH RePORTER

Who could benefit from this research

Could help

Patients suffering from infections caused by antibiotic-resistant bacteria would be ideal candidates to benefit from this research.

Less likely to help

Patients with infections caused by non-bacterial pathogens or those not affected by antibiotic resistance may not benefit from this research.

What this research studies

This research investigates how bacteria move proteins across their membranes, which is crucial for their ability to cause infections and develop resistance to antibiotics. The focus is on a specific system called the Type IV secretion system (T4SS), which allows bacteria to transport important molecules into host cells. By studying the Dot/Icm T4SS in Legionella pneumophila, the research aims to uncover the mechanisms that enable bacteria to evade the immune system and thrive in hostile environments. This could lead to a better understanding of bacterial infections and antibiotic resistance.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for combating antibiotic-resistant bacterial infections.

How similar studies have gone: Previous research has shown success in understanding bacterial secretion systems, indicating that this approach has potential for significant findings.

Where this research is happening

  • University of Missouri-Columbia
    Columbia, United States
    Active

Researchers

  • Principal investigator: Durie, Clarissa Lynn — University of Missouri-Columbia
  • Study coordinator: Durie, Clarissa Lynn

Related research

Other NIH-funded projects on the same topics.

  • Boosting immune response to fight cancer

    This study is exploring a new way to help your immune system better fight cancer by tweaking certain cells in your body, and it aims to improve treatment for people with advanced cancer.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-9868156

  • Interface between immune cells and scarring in the eye

    This grant looks at how immune cells influence scar formation in the cornea after injury and how this affects vision.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11609392

  • Understanding cell-cleanup problems in C9ORF72-related ALS/FTD

    Researchers are studying why the body's cell-cleanup systems fail in a genetic form of ALS/FTD to pave the way for better treatments.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11606636

  • Molecular clues to endometriosis-related infertility

    This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11595518

  • A universal Shigella vaccine using SAVE to protect people of all ages

    A new vaccine approach called SAVE aims to prevent Shigella-related dysentery across all ages, including children and adults, by targeting conserved bacterial components.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11464403

  • Biomarkers that predict osteoarthritis risk in people at higher risk

    A long-term study will look for protein markers in body fluids that could predict who will develop knee osteoarthritis before symptoms appear.

    NIH research University of Missouri-Columbia · Columbia, United States · NIH-11461903

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.